Skip to main content
ImmuneCited

Omega-3 Fatty Acids (EPA/DHA) für Chronic Inflammation

A

The VITAL trial and multiple randomized controlled trials demonstrate omega-3 fatty acids may help reduce CRP and modulate inflammatory cytokines. DHA showed stronger anti-inflammatory effects than EPA, lowering 4 pro-inflammatory proteins versus 1 in a randomized study.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dchronic\u002Dinflammation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Fazit

The VITAL trial and multiple randomized controlled trials demonstrate omega-3 fatty acids may help reduce CRP and modulate inflammatory cytokines. DHA showed stronger anti-inflammatory effects than EPA, lowering 4 pro-inflammatory proteins versus 1 in a randomized study.

Key Study Findings

Review
Immunosenescence and inflammaging: Mechanisms and modulation through diet and lifestyle.
Dose: None vs.: None Outcome: Immunosenescence and inflammaging modulation Wirkung: None None

Population: Aging adults (review)

Observational Study n=21 4 weeks Single-blind
Associations between omega-3 fatty acid-derived lipid mediators and markers of inflammation in older subjects with …
Dose: None vs.: None Outcome: Associations between omega-3 SPMs and inflammatory markers Wirkung: None None

Population: Older adults with low-grade chronic inflammation (CRP>2)

Review
The Impact of Flavonoids and Omega-3 in Mitigating Frailty Syndrome to Improve Treatment Outcomes in …
Dose: None vs.: None Outcome: None Wirkung: None None

Population: Review of flavonoids and omega-3 in PAD with frailty

Review
Proresolving Lipid Mediators in the Respiratory System.
Dose: None vs.: None Outcome: None Wirkung: None None

Population: None

Review
Sarcopenia in the Aging Process: Pathophysiological Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches.
Dose: None vs.: None Outcome: Sarcopenia progression and muscle function Wirkung: None None

Population: Older adults with sarcopenia (review)

Review
Immunomodulatory Effects of Omega-3 Fatty Acids: Mechanistic Insights and Health Implications.
Dose: None vs.: None Outcome: None Wirkung: None None

Population: review of omega-3 fatty acids' immunomodulatory effects

Key Statistics

30

Studien

30000

Teilnehmer

Positive

A

Bewertung

Referenced Papers

Annual review of … 2025 13 Zitierungen
International immunopharmacology 2023 8 Zitierungen
Toxicology and applied … 2022 20 Zitierungen
Reproductive medicine and … 2020 11 Zitierungen
Frontiers in immunology 2017 74 Zitierungen
European journal of … 2016 102 Zitierungen
Clinical journal of … 2016 4 Zitierungen
Allergology international : … 2015 205 Zitierungen
Current atherosclerosis reports 2004 464 Zitierungen
Current atherosclerosis reports 2001 2 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:
250-500 mg combined EPA/DHA/day
antiinflammatory:
1,000-3,000 mg combined EPA/DHA/day

Obergrenze: 3,000 mg/day EPA+DHA (FDA-recognized as safe)

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
None -- Positive --
None 4 weeks Positive 21
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Positive --
None -- Positive --
None -- Mixed --

Beste Einnahmezeit: With meals

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Fishy aftertaste and burping
  • Gastrointestinal discomfort (nausea, diarrhea)
  • Increased bleeding risk at high doses
  • Potential LDL cholesterol increase at very high doses

Bekannte Wechselwirkungen

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • Blood pressure medications (additive blood pressure lowering)
  • Orlistat (may reduce omega-3 absorption)
  • Cyclosporine (may modify immunosuppressive effects)

Tolerierbare Höchstaufnahmemenge: 3,000 mg/day EPA+DHA (FDA-recognized as safe)

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Omega-3 Fatty Acids (EPA/DHA) help with Chronic Inflammation?
Based on 30 studies with 30,000 participants, there is strong evidence from multiple clinical trials that Omega-3 Fatty Acids (EPA/DHA) may support Chronic Inflammation management. Our evidence grade is A (Strong Evidence).
How much Omega-3 Fatty Acids (EPA/DHA) should I take for Chronic Inflammation?
Studies have used various dosages. A commonly studied range is 250-500 mg combined EPA/DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (EPA/DHA)?
Reported side effects may include Fishy aftertaste and burping, Gastrointestinal discomfort (nausea, diarrhea), Increased bleeding risk at high doses, Potential LDL cholesterol increase at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (EPA/DHA) and Chronic Inflammation?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 30 peer-reviewed studies with 30,000 total participants. The overall direction of effect is positive.

Related Evidence

Omega-3 Fatty Acids (EPA/DHA) für andere Beschwerden

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.